Finoriq research workspace
Ainos, Inc. (AIMD) Institutional Holdings & 13F Ownership
Ainos, Inc. offers AI Nose, an AI-based electronic olfaction system, which uses a smell. Review AIMD institutional holders, 13F ownership, and position changes on Finoriq.
Company Snapshot
Ainos, Inc., a dual-platform company, focusing artificial intelligenceĀbased smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women's health sectors. In addition, it develops VELDONA, a low-dose oral interferon platform for human and animal health applications, targeting rare, autoimmune, and infectious diseases. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in Houston, Texas. Ainos, Inc. is a subsidiary of Taiwan Carbon Nano Technology Corporation.
- Company
- Ainos, Inc. (AIMD)
- Ticker
- AIMD
- Market Cap
- $13.6M
- Latest Price
- $1.60
- Industry
- Computer Hardware
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.